Do you want to read an article? Please log in or register.
Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
Lung Cancer
RECOMMENDED
Related content
COMMENTED
Lung Cancer
Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study
Thorax.
Barclay ME, Lyratzopoulos G, Walter FM, Jefferies S, Peake MD, Rintoul RC
doi: 10.1136/thoraxjnl-2018-212456.
Lung Cancer
Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function
Acta Oncol.
Ishihara T, Yamada K, Harada A, Yukiue H, Tanahashi M, Niwa H, Matsui T, Yokomura K, Ejima Y, Sasaki R
doi: 10.1080/0284186X.
RECOMMENDED
Lung Cancer
Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database
★ 1
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1007/s12325-020-01322-0.
RECOMMENDED
Further Publications
Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur J Cardiothorac Surg
Kanzaki R, Nagoya A, Kanou T, Ose N, Funaki S, Minami M, Okamoto Y, Tabuchi H, Hoshino T, Tajima T, Fujii M, Ohno Y, Shintani Y
doi: 10.1093/ejcts/ezaa333
RECOMMENDED
Lung Cancer
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening
Clin Lung Cancer.
Tolwin Y, Gillis R, Agmon IN, Shrem NS, Rosenbaum E, Peled N
doi: 10.1016/j.cllc.2019.06.010.
Lung Cancer
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States
Clin Lung Cancer.
Cushman TR, Jones B, Akhavan D, Rusthoven CG, Verma V, Salgia R, Sedrak M, Massarelli E, Welsh JW, Amini A
doi: 10.1016/j.cllc.2020.09.004.
RECOMMENDED
Lung Cancer
Local ablative treatment for synchronous single organ oligometastatic lung cancer - A propensity score analysis of 180 patients
Lung Cancer.
Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
Lung Cancer.
Stahel RA, Curioni-Fontecedro A, Rohrmann S, Dafni U, Sandner U, Opitz I, Andratschke N, Franzen D, Dimopoulou G, Matthes KL, Kohler M, Guckenberger M, Weder W
doi: 10.1016/j.lungcan.2020.05.037.
RECOMMENDED
Lung Cancer
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Tessema M, Tassew DD, Yingling CM, Do K, Picchi MA, Wu G, Petersen H, Randell S, Lin Y, Belinsky SA, Tesfaigzi Y
doi: 10.1016/j.lungcan.2020.05.017.